Lydia Castro-Perigo

Lydia Castro-Perigo serves as a key procurement professional within the National Cancer Institute (NCI), supporting the agency’s mission to accelerate cancer research through strategic acquisition of advanced scientific and technical services. She manages a diverse portfolio of contracts focused on research infrastructure, data analytics, and operational support, ensuring alignment with NCI’s priorities in genomic analysis, precision medicine, and translational science. Her acquisitions primarily enable high-capability laboratories and computational platforms essential for large-scale cancer data processing and bioinformatics workflows. Her primary contractor relationships center on Roche Diagnostics Corporation, reflecting a strong reliance on industry leaders in diagnostic technologies and laboratory automation. She also engages with a broad spectrum of technology and management consulting firms, fostering partnerships that bridge clinical research needs with enterprise-grade computing solutions. Her procurement approach emphasizes performance-based outcomes, vendor scalability, and technical interoperability across research ecosystems. Castro-Perigo demonstrates a balanced commitment to socioeconomic contracting, with an equal split between 8(a) competed set-asides and open competitions. This pattern signals a deliberate effort to integrate qualified small businesses—particularly those certified under the 8(a) program—into high-impact research support roles while maintaining competitive rigor for complex technical requirements. Her contracting strategy ensures equitable access for disadvantaged businesses without compromising mission-critical performance standards. Her procurement focus is concentrated in NAICS 541611 (administrative and management consulting services), 518210 (computing infrastructure and data processing), and 541519 (other computer-related services). These categories reflect her specialization in procuring bioinformatics platforms, cloud-based data repositories, laboratory information management systems, and operational consulting services that support NCI’s data-intensive research environment. Her expertise lies at the intersection of scientific research needs and enterprise IT procurement, enabling the translation of genomic and clinical data into actionable insights.